Ambit Biosciences Corp (NASDAQ:AMBI) Investor Alert: Lawsuit Filed to Halt Takeover by Daiichi Sankyo Company
An investor, who currently holds shares of Ambit Biosciences Corp (NASDAQ:AMBI), filed a lawsuit in effort to halt the proposed takeover of Ambit Biosciences Corp. by Daiichi Sankyo Company for $15 per share.
View full press release